Pancreatitis Trial, Recruiting NCT06549725 Sponsor: Lipidica, a.s. Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT06549725
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1 (people with pancreatic cancer):

  • You are 18 years of age or older
  • You have agreed to take part by signing a consent form
  • You have been diagnosed with pancreatic cancer that has been confirmed by a tissue test and can be removed by surgery

Group 2 (people at high risk of pancreatic cancer):

  • You are 18 years of age or older
  • You have agreed to take part by signing a consent form
  • You have a high risk of pancreatic cancer because of at least one of the following:
    • Two or more close blood relatives (parents, siblings, children, grandparents, aunts, uncles) on the same side of the family have had pancreatic cancer
    • You carry an inherited gene change called STK11 (LKB1), regardless of family history
    • You carry an inherited gene change called CDKN2A (affecting p16), regardless of family history
    • You carry an inherited gene change in one of these genes — APC, ATM, BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, EPCAM, PALB2, or TP53 — AND at least one close blood relative has had pancreatic cancer
    • You have hereditary pancreatitis (a recurring or long-term inflammation of the pancreas linked to an inherited change in the PRSS1 gene)
  • You also meet specific age requirements depending on your risk factor (confirm with trial site for your exact age requirement)

Who may not be able to join:

Group 1 (people with pancreatic cancer):

  • You have had any other type of cancer in the past
  • You currently have a cancer that cannot be cured
  • You are not well enough to have surgery to fully remove the tumor
  • You follow a vegan or vegetarian diet

Group 2 (people at high risk):

  • You are pregnant or planning to become pregnant in the next 12 months
  • You have had any type of cancer in the past
  • You currently have a cancer that cannot be cured
  • You are unable to have the required scans or blood tests as part of the study
  • You follow a vegan or vegetarian diet

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Karolina Kasparova, Lipidica, a.s.

Phone: +420723 242 544

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lipidica, a.s.
Registry
ClinicalTrials.gov
Start date
10 September 2024
Est. completion
26 September 2027

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

The primary objective is to verify that the investigational IVDSW can discriminate between results of patients with PaC and persons without PaC but at higher risk of this cancer disease due to their predispositions.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov